Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC42931 | Calystegine B2 |
![]() |
|
DC42930 | Coclauril |
![]() |
|
DC42929 | Ssioriside |
![]() |
|
DC42928 | 24-Methylenecycloartanol acetate |
![]() |
|
DC42927 | 3',5,5',7-Tetrahydroxy-4',6-dimethoxyflavone |
![]() |
|
DC42926 | Cedrelone |
![]() |
|
DC42925 | GSK-5503A |
Novel selective CRAC channel blocker
More description
|
![]() |
DC42923 | 26-Nor-8-oxo-alpha-onocerin |
![]() |
|
DC42922 | AM6545 |
Peripheral CB1 cannabinoid receptor antagonist and appetite suppressant.
More description
|
![]() |
DC42920 | Cannabidiolic acid |
![]() |
|
DC42918 | VU0364572 TFA salt |
Potent, orally bioavailable and CNS penetrant M1 agonist with high selectivity, clean ancillary pharmacology and enantiospecific activity
More description
|
![]() |
DC42917 | Kobophenol A |
![]() |
|
DC42916 | Demethylmurrayanine |
![]() |
|
DC42915 | Phyltetralin |
![]() |
|
DC42914 | 6'-O-Galloyl paeoniflorin |
![]() |
|
DC42913 | 2-Desoxy-4-epi-pulchellin |
![]() |
|
DC42911 | ML137 |
Highly selective M1 positive allosteric modulator (PAM)
More description
|
![]() |
DC42910 | Auraptenol |
![]() |
|
DC42909 | Meliasenin B |
![]() |
|
DC42908 | 5-Methyl cromolyn (C5OH) |
Novel S100P Inhibitor
More description
|
![]() |
DC42907 | MPT0B014 |
Novel inducer of G2/M arrest with down-regulation of Cdc (Tyr15) and Cdc25C, and up-regulation of cyclin B1, phospho-Cdc2 (Thr161) and Aurora A/B
More description
|
![]() |
DC42906 | Daclatasvir (BMS790052) |
A HCV NS5A inhibitor
More description
|
![]() |
DC42905 | SIRT6-IN-1 |
Novel SIRT6 inhibitor, reducing glycemia and improving oral glucose tolerance in unfed wild-type mice
More description
|
![]() |
DC42904 | 3-O-cis-p-Coumaroyltormentic acid |
![]() |
|
DC42903 | Bozepinib |
Novel antitumor agent, inducing PKR-mediated apoptosis and synergizing with IFN
More description
|
![]() |
DC42902 | Scutebata A |
![]() |
|
DC42901 | Ganoderenic acid H |
![]() |
|
DC42900 | BPAM344 |
A potent positive allosteric modulator (PAM) on the three KAR subunits GluK1b, GluK2a, and GluK3a. BPAM344 potentiates glutamate-evoked currents of GluK2a 21-fold, and noticeably decreases desensitization kinetics (from 5.5 to 775 ms).
More description
|
![]() |
DC42899 | Azaperone tartrate |
Dopamine antagonist, also having antihistaminic and anticholinergic properties
More description
|
![]() |
DC42898 | 1beta-Hydroxyeuscaphic acid |
![]() |